Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hikma Pharmaceuticals Plc (HIK.LN)

Hikma Pharmaceuticals Plc (HIK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hikma Pharmaceuticals Plc 1 New Burlington Place London W1S 2HR GBR

https://www.hikma.com P: 207-399-2760

Description:

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

Key Statistics

Overview:

Market Capitalization, $K 4,271,291
Shares Outstanding, K 221,885
Annual Sales, $ 2,875 M
Annual Net Income, $ 190,000 K
% of Insider Shareholders 17.55%
% of Institutional Shareholders 62.70%

Growth:

1-Year Return 6.35%
3-Year Return -16.60%
5-Year Return 11.97%
5-Year Revenue Growth 6.79%
5-Year Earnings Growth -6.11%
5-Year Dividend Growth 12.28%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 0.85
EPS Growth vs. Prev Year 0.02%
Annual Dividend Rate, $ 0.62
Annual Dividend Yield 2.96%
Most Recent Dividend 0.470 on 03/21/24
Next Ex-Dividends Date 03/21/24
Dividend Payable Date 05/03/24
Dividend Payout Ratio 72.75%

HIK.LN Ratios

Ratio
Price/Earnings ttm 28.39
Price/Earnings forward 12.06
Return-on-Equity % 8.77%
Return-on-Assets % 4.15%
Profit Margin % 6.61%
Debt/Equity 0.47
Price/Sales 1.87
Price/Book 2.44
Book Value/Share 7.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar